Merck Operating Income 2010-2024 | MRK

Merck operating income for the twelve months ending June 30, 2024 was $16.048B, a 151.26% increase year-over-year.

  • Merck annual operating income for 2023 was $2.954B, a 83.84% decline from 2022.
  • Merck annual operating income for 2022 was $18.282B, a 38.51% increase from 2021.
  • Merck annual operating income for 2021 was $13.199B, a 137.91% increase from 2020.

Merck Operating Income 2010-2024 | MRK

  • Merck annual operating income for 2023 was $2.954B, a 83.84% decline from 2022.
  • Merck annual operating income for 2022 was $18.282B, a 38.51% increase from 2021.
  • Merck annual operating income for 2021 was $13.199B, a 137.91% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B